Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection
Clinical trial NCT02722837 · COMPLETED
Trial details
- NCT number
- NCT02722837
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-04
- Primary completion
- 2017-06-26
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.